Literature DB >> 19133260

Corneal stroma PDGF blockade and myofibroblast development.

Harmeet Kaur1, Shyam S Chaurasia, Fabricio W de Medeiros, Vandana Agrawal, Marcella Q Salomao, Nirbhai Singh, Balamurali K Ambati, Steven E Wilson.   

Abstract

Myofibroblast development and haze generation in the corneal stroma is mediated by cytokines, including transforming growth factor-beta (TGF-beta), and possibly other cytokines. This study examined the effects of stromal PDGF-beta blockade on the development of myofibroblasts in response to -9.0 diopter photorefractive keratectomy in the rabbit. Rabbits that had haze generating photorefractive keratectomy (PRK, for 9 diopters of myopia) in one eye were divided into three different groups: stromal application of plasmid pCMV.PDGFRB.23KDEL expressing a subunit of PDGF receptor b (domains 2-3, which bind PDGF-B), stromal application of empty plasmid pCMV, or stromal application of balanced salt solution (BSS). The plasmids (at a concentration 1000ng/microl) or BSS was applied to the exposed stroma immediately after surgery and every 24h for 4-5 days until the epithelium healed. The group treated with pCMV.PDGFRB.23KDEL showed lower alphaSMA+ myofibroblast density in the anterior stroma compared to either control group (P<or=0.001). Although there was also lower corneal haze at the slit lamp at one month after surgery, the difference in haze after PDGF-B blockade was not statistically significant compared to either control group. Stromal PDGF-B blockade during the early postoperative period following PRK decreases stromal alphaSMA+ myofibroblast generation. PDGF is an important modulator of myofibroblast development in the cornea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133260      PMCID: PMC2674136          DOI: 10.1016/j.exer.2008.12.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  30 in total

Review 1.  Keratocyte and fibroblast phenotypes in the repairing cornea.

Authors:  M E Fini
Journal:  Prog Retin Eye Res       Date:  1999-07       Impact factor: 21.198

Review 2.  Biology of platelet-derived growth factor and its involvement in disease.

Authors:  Ricardo H Alvarez; Hagop M Kantarjian; Jorge E Cortes
Journal:  Mayo Clin Proc       Date:  2006-09       Impact factor: 7.616

Review 3.  Apoptosis in the initiation, modulation and termination of the corneal wound healing response.

Authors:  Steven E Wilson; Shyam S Chaurasia; Fabricio W Medeiros
Journal:  Exp Eye Res       Date:  2007-06-21       Impact factor: 3.467

4.  Stromal haze, myofibroblasts, and surface irregularity after PRK.

Authors:  Marcelo V Netto; Rajiv R Mohan; Sunilima Sinha; Ajay Sharma; William Dupps; Steven E Wilson
Journal:  Exp Eye Res       Date:  2005-11-21       Impact factor: 3.467

Review 5.  Growth factors: importance in wound healing and maintenance of transparency of the cornea.

Authors:  J Imanishi; K Kamiyama; I Iguchi; M Kita; C Sotozono; S Kinoshita
Journal:  Prog Retin Eye Res       Date:  2000-01       Impact factor: 21.198

Review 6.  Mechanism of action and in vivo role of platelet-derived growth factor.

Authors:  C H Heldin; B Westermark
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

7.  Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea.

Authors:  W J Kim; R R Mohan; R R Mohan; S E Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-06       Impact factor: 4.799

8.  Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly.

Authors:  J V Jester; J Huang; P A Barry-Lane; W W Kao; W M Petroll; H D Cavanagh
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

9.  Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.

Authors:  Balamurali K Ambati; Emory Patterson; Pooja Jani; Crystal Jenkins; Eric Higgins; Nirbhai Singh; Tushar Suthar; Nehali Vira; Kimberly Smith; Ruth Caldwell
Journal:  Br J Ophthalmol       Date:  2006-12-06       Impact factor: 4.638

10.  A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  April E Nedeau; Richard J Bauer; Katherine Gallagher; Haiying Chen; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Exp Cell Res       Date:  2008-04-25       Impact factor: 3.905

View more
  28 in total

1.  PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.

Authors:  Sayaka Yuzawa; Mitsunobu R Kano; Takahiro Einama; Hiroshi Nishihara
Journal:  Med Oncol       Date:  2012-03-09       Impact factor: 3.064

Review 2.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

3.  Development of wound healing models to study TGFβ3's effect on SMA.

Authors:  Sriniwas Sriram; Jennifer A Tran; Xiaoqing Guo; Audrey E K Hutcheon; Andrius Kazlauskas; James D Zieske
Journal:  Exp Eye Res       Date:  2017-06-06       Impact factor: 3.467

Review 4.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

5.  Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.

Authors:  Hong-Wei Pan; Jin-Tang Xu; Jian-Su Chen
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

6.  TGFβ and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo.

Authors:  Vivek Singh; Ritika Jaini; André A M Torricelli; Marcony R Santhiago; Nirbhai Singh; Bala K Ambati; Steven E Wilson
Journal:  Exp Eye Res       Date:  2014-02-26       Impact factor: 3.467

7.  Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.

Authors:  Harmeet Kaur; Shyam S Chaurasia; Vandana Agrawal; Chikako Suto; Steven E Wilson
Journal:  Exp Eye Res       Date:  2009-03-12       Impact factor: 3.467

8.  Transforming growth factor β and platelet-derived growth factor modulation of myofibroblast development from corneal fibroblasts in vitro.

Authors:  Vivek Singh; Flavia L Barbosa; Andre A M Torricelli; Marcony R Santhiago; Steven E Wilson
Journal:  Exp Eye Res       Date:  2014-01-12       Impact factor: 3.467

9.  Expression of PDGF receptor-alpha in corneal myofibroblasts in situ.

Authors:  Harmeet Kaur; Shyam S Chaurasia; Vandana Agrawal; Steven E Wilson
Journal:  Exp Eye Res       Date:  2009-04-01       Impact factor: 3.467

10.  Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Authors:  Jo Nadine Fleming; Howard M Shulman; Richard A Nash; Pamela Y Johnson; Thomas N Wight; Allen Gown; Stephen M Schwartz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.